微创再次主动脉瓣置换术:多中心注册研究结果
该研究基于SURD-IR国际注册数据库,回顾性分析63例既往心脏手术后行微创再次主动脉瓣置换术的患者,使用免缝合或快速部署瓣膜。结果显示无院内死亡,并发症发生率可接受,术后恢复快。
要点
- 微创再次主动脉瓣置换术使用免缝合或快速部署瓣膜安全可行。
- 该队列无院内死亡,并发症发生率可接受。
- 术后恢复快,中位ICU停留1天,中位住院10天。
核心结论
- 微创再次主动脉瓣置换术使用免缝合或快速部署瓣膜是安全可行的治疗策略,无死亡率且并发症发生率可接受。
研究设计与样本
- 回顾性多中心注册研究,从SURD-IR国际注册数据库2007至2018年3651例患者中筛选63例既往心脏手术者。
主要发现
- 平均年龄75.3±7.8岁,logistic EuroSCORE 10.1。
- 43例(68.3%)经迷你胸骨切开,20例(31.7%)经右前胸廓切开。
- 31例(49.2%)使用Perceval瓣膜,32例(50.8%)使用Intuity瓣膜。
- 平均主动脉阻断时间57.8±23.2分钟,体外循环时间95.0±34.3分钟。
- 无中转全胸骨切开,无院内死亡;术后缺血性脑事件3例(4.8%),需起搏器植入2例(3.6%),需再次手术止血5例(8.9%),透析1例(1.6%)。
关键数值与推荐
- 术后中位ICU停留1天,中位住院时间10天。
- 超声心动图评估1例患者出现显著术后主动脉瓣反流。
临床怎么用
- 对于既往心脏手术需再次主动脉瓣置换的患者,可考虑微创入路联合免缝合或快速部署瓣膜。
局限性
- 回顾性研究,样本量小(63例),来自注册数据库,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Reoperation for aortic valve replacement can be challenging and is usually associated with an increased risk for complications and mortality. The study aim was to report the results of a multicenter cohort of patients who underwent minimally invasive reoperative aortic valve replacement with a sutureless or rapid-deployment prosthesis. METHODS: From 2007 to 2018 data from 3651 patients were retrospectively collected from the Sutureless and Rapid-Deployment Aortic Valve Replacement International Registry. Of them, 63 patients who had previously undergone cardiac surgery represented the study population. In-hospital clinical and echocardiographic outcomes were recorded. RESULTS: Mean age of the selected 63 patients was 75.3 ± 7.8 years and logistic EuroSCORE 10.1. Surgery was performed by ministernotomy in 43 patients (68.3%) and by anterior right thoracotomy in 20 (31.7%); 31 patients (49.2%) received the Perceval valve (Livanova PLC, London, UK) and 32 (50.8%) the Intuity valve (Edwards Lifesciences, Irvine, CA). Mean cross-clamp time was 57.8 ± 23.2 minutes and cardiopulmonary bypass time 95.0 ± 34.3 minutes. Neither conversion to full sternotomy nor in-hospital deaths occurred. Postoperative events were ischemic cerebral events in 3 patients (4.8%), need for pacemaker implantation in 2 (3.6%), bleeding requiring reoperation in 5 (8.9%), and dialysis in 1 (1.6%). Median intensive care unit stay was 1 day, and median length of hospital stay was 10 days. On echocardiographic evaluation 1 patient showed a significant postoperative aortic regurgitation. CONCLUSIONS: Minimally invasive reoperative aortic valve replacement with a sutureless or rapid-deployment prosthesis is a safe and feasible treatment strategy, resulting in fast recovery and improved postoperative outcome with no mortality and an acceptable complication rate.
引用
- Santarpino G, Berretta P, Kappert U, et al. Minimally Invasive Redo Aortic Valve Replacement: Results From a Multicentric Registry (SURD-IR). Ann Thorac Surg. 2020. PMID: 31954690. doi:10.1016/j.athoracsur.2019.11.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。